Goodness Growth Holdings Launches New Line of Cannabis Edibles

- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced the launch of HiColor™ gummies and availability in Maryland through the Company's wholesale and retail channels. The new line of cannabis infused edibles will be available in three formulations and five gourmet flavors.

"HiColor Gummies are an exciting addition to our growing portfolio of brands that are well positioned for both medical-only and adult-use markets," said Harris Rabin , Chief Marketing Officer for Goodness Growth. "The extra strength 10mg THC and the balanced CBD:THC formulations help create desirable outcomes for every occasion. The delightful flavors used in HiColor Gummies were selected and developed by our edibles R&D team, led by Chef Michelle Mango . The colorful, streamlined packaging featuring a vibrant style creates a premium, flavorful feeling that matches the gummies themselves."

HiColor Gummies are offered in 10 mg THC, 10:10 CBD:THC, and 5:5 CBD:THC formulations built  to meet the needs of a variety of cannabis consumers. At launch, the gummies are available in Key Lime, Concord Grape, Hawaiian Pineapple, Alfonso Mango , Oxnard Strawberry, and a variety pack. The gummies are vegan, gluten free, non-GMO and use only natural flavors.

The full brand launch of HiColor follows a soft, exclusive debut in November at select Maryland retailers. Hi-Color Gummies will be available this month at Goodness Growth's Green Goods ® retail locations in Baltimore and Frederick, Maryland , and other licensed dispensaries across the state.

Subject to regulatory approvals, the Company plans to expand the HiColor brand to other markets, including New York and Minnesota , which just announced the allowance of cannabis-infused edibles in the state's medical cannabis program starting August 2022 .

About Goodness Growth Holdings, Inc.

Goodness Growth Holdings, Inc., is a physician-led, science-focused holding company whose mission is to bring the power of plants to the world. The Company's operations consist primarily of its multi-state cannabis company subsidiary, Vireo Health, Inc., and its science and intellectual property incubator, Resurgent Biosciences, Inc. The Company manufactures proprietary, branded cannabis products in environmentally friendly facilities and state-of-the-art cultivation sites and distributes its products through its growing network of Green Goods ® and other retail locations and third-party dispensaries. Its team of more than 500 employees are focused on the development of differentiated products, driving scientific innovation of plant-based medicines, and developing meaningful intellectual property. Today, the Company is licensed to grow, process, and/or distribute cannabis in eight markets and operates 18 dispensaries across the United States . For more information about Goodness Growth Holdings, please visit www.goodnessgrowth.com .

Contact Information
Media Inquiries:
Albe Zakes
Vice President, Corporate Communications
albezakes@vireohealth.com
(267) 221-4800

View original content to download multimedia: https://www.prnewswire.com/news-releases/goodness-growth-holdings-launches-new-line-of-cannabis-edibles-301438947.html

SOURCE Goodness Growth Holdings, Inc.

News Provided by PR Newswire via QuoteMedia

The Conversation (0)
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said that the country’s 2025 cannabis import quota has officially been reduced by the International Narcotics Control Board (INCB) from 101 tonnes to 88 tonnes, Business of Cannabis reported on Tuesday (October 28).Demand over projections and idle permits... Keep Reading...
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...

Latest Press Releases

Related News